Clinical data software firm Medrio has signed an extended pact with CRO Clinartis under the IT company’s “partner program.”
Hollywood, FL-based Clinartis and Medrio already have business dealings through a number of Phase I studies, which has seen the CRO has use Medrio’s m1 product for trial data capture. This deal will now be extended--financial details were not disclosed.
The San Francisco, CA-based Medrio’s partner program is a collaborative effort that seeks to put Medrio resources together with CROs and consultancies. The program is designed to offer extensive training, sales, product insights, and marketing support to all partners, the company said in a statement.
"We are excited to announce this new partnership," explained Scott Weidley, VP of sales, marketing and customer success at Medrio. "We are pleased that Clinartis has utilized our software in their studies, and we look forward to continuing our work with them."
"Medrio's robust, versatile, and easy-to-deploy EDC [electronic data capture] system is a perfect fit for our dynamic and efficient operational mode," added Aramayis Kocharyan, VP of regulatory and compliance at Clinartis.
"This partnership with Medrio allows Clinartis to offer cutting-edge EDC solutions to support our sponsors' clinical development programs."
-read the release